Expectant parents in Europe will soon have access to leading prenatal testing kits that are widely utilised in Australia to diagnose a range of life quality impacting diseases, including Down Syndrome, courtesy of biotech company Genetic Technologies (ASX: GTG) expanding their test kit distribution into Europe. Mothers-to-be typically perform a Non-Invasive Prenatal Test (NIPT) any
Read MoreThe one-size-fits-all approach to medicine is on its way out with the rise of personalised medicine. The development of technologies to individualise healthcare for each person holds much promise for tackling disease treatment and prevention. A prime example of this is the development of genetic testing for the BRCA genes. Inherited genetic mutations within these
Read MoreThe content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.